Stock listing

NASDAQ:GNVC GenVec Inc Stock

Follow GenVec Inc into a list and get an email when it puts out news.

Last close · NASDAQ:GNVC

$7.19 USD

Close on Jun 15, 2017 · No longer trades

Dec 1, 2016 to last close +114.0% · daily closes, Dec 1, 2016 – Jun 15, 2017
Lowest – highest close
$2.96 – $8.79 USDSince Dec 1, 2016 · lowest Dec 5, 2016 · highest Jan 10, 2017

Delisted NASDAQ:GNVC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:GNVC
Asset type
Stock
Exchange
NASDAQ
Currency
USD

GenVec Inc on 6ix

Decks
5 decks · latest Jun 17, 2011

Decks

DeckKindSlidesDate
Shareholder Meeting (June 2011)Shareholder meeting21 slidesJun 17, 2011
American Society of Gene Therapy 2008Conference34 slidesJun 2, 2008
Shareholder Meeting (June 2006)Shareholder meeting24 slidesJun 22, 2006
Merger or Acquisition (July 2003)Merger or acquisition35 slidesJul 30, 2003
Needham & Co. Second Annual Biotechnology Conference 2003Conference26 slidesJun 5, 2003

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael Richman
Other companies: NextCure, Inc. (President & CEO · Since at least May 8, 2019); Palvella Therapeutics, Inc. (Director · Jul 15, 2015 – Jun 21, 2023 · Past); Acer Therapeutics Inc (Director · Jun 30, 2015 – Sep 30, 2016 · Past)
Director · Nov 13, 2015 – Jun 16, 2017 · Past
Wayne T Hockmeyer
Other companies: Baxalta Inc (Director · Jun 9, 2015 – Jun 3, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Jun 3, 2010 – Aug 5, 2014 · Past); Baxter International Inc. (Director · May 4, 2010 – May 5, 2015 · Past)
Director · Jun 16, 2010 – Jun 16, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about GenVec Inc.